Biotech Investors & VC Firms in Asia-Pacific
571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.
Seoul Investment Partners
SeoulSeed–Late Stage
The Wells Investment
SeoulSeed–Late Stage
Dalton Venture
ShanghaiSeed–Series B
IMM Investment
KangnamPre-Seed–Growth$3M – $54M
Union Investment Partners
SeoulSeed–Series A
Yuuwa Capital
PerthPre-Seed–Late Stage
CDF-Capital
ShenzhenSeed–Late Stage
Comway Capital Ltd.
ShanghaiSeed–Series B
D3 Jubilee
SeoulSeed–Late Stage
Hiroshima Innovation Network
HiroshimaPre-Seed–Growth
Shiyu Capital
HainanSeed–Late Stage
Zhejiang Paradise
HangzhouSeed
Zhongguancun Science City Science
Beijing
Good Startup
BrusselsSeed–Late Stage
5 people
Oceanpine Capital
BeijingSeed–Late Stage
5 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Summitview Capital
ShanghaiSeed–Late Stage
5 people
ICICI Venture
MumbaiGrowth–Late Stage$500K – $2.5M
1 person
Ennovation Ventures
ShanghaiSeed–Series B
5 people
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Vincera Capital
TaipeiSeed–Late Stage$500K – $10M
2 people
Company K Partners
SeoulSeed–Late Stage$2.2M – $44M
GVFL Ltd.
AhmedabadSeed–Late Stage$250K – $25M
IBK Capital
SeoulSeed–Series B$2K – $21M
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4134)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3764)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Healthtech Investors & VC Firms (3408)
Data sourced from public filings and firms' own websites — see our methodology.







